Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure

Journal of Cell Science

Volumn 120, Issue 13, 2007, Pages 2284-2294

  Ding, Boxiao ^a   Chi, Sung Gil ^b   Kim, Se Heon ^a   Kang, Suki ^a   Cho, Jae Ho ^a   Kim, Dong Su ^c   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Genomine Inc   (South Korea)

Author keywords

H2O2; Oxidative stress; p53; RNA interference (RNAi); ROS; SiHa

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; HYDROGEN PEROXIDE; PROTEIN E6; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; UTERINE CERVIX CARCINOMA;

ANTIOXIDANTS; DEOXYGUANOSINE; DNA DAMAGE; DOWN-REGULATION; FEMALE; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; HYDROGEN PEROXIDE; ONCOGENE PROTEINS, VIRAL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 34447521989     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.002345     Document Type: Article

References (49)

1. Abdulkarim, B., Sabri, S., Deutsch, E., Chagraoui, H., Maggiorella, L., Thierry, J., Eschwege, F., Vainchenker, W., Chouaib, S. and Bourhis, J. (2002). Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene 21, 2334-2346.
2. Achanta, G. and Huang, P. (2004). Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 64, 6233-6239.
3. Beckman, K. B. and Ames, B. N. (1997). Oxidative decay of DNA. J. Biol. Chem. 272, 19633-19636.
4. Bensaad, K. and Vousden, K. H. (2005). Savior and slayer: the two faces of p53. Nat. Med. 11, 1278-1279.
5. Breen, A. P. and Murphy, J. A. (1995). Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18, 1033-1077.
6. Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V. and Chumakov, P. M. (2004). Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600.
7. Burdon, R. (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775-794.
8. Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullmann, A. and Hoppe-Seyler, F. (1995). Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10, 927-936.
9. Butz, K., Whitaker, N., Denk, C., Ullmann, A., Geisen, C. and Hoppe-Seyler, F. (1999). Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 18, 2381-2386.
10. Chae, H. Z., Chung, S. J. and Rhee, S. G. (1994a). Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269, 27670-27678.
11. Chae, H. Z., Uhm, T. B. and Rhee, S. G. (1994b). Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. USA 91, 7022-7026.
12. de Hann, J. B., Bladier, C., Griffiths, P., Kelner, M., O'Shea, R. D., Cheung, N. S., Bronson, R. T., Silvestro, M. J., Wild, S., Zheng, S. S. et al. (1998). Mice with homozygous null mutation for the most abundant glutathione peroxidase, GPX1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem. 273, 22528-22536.
13. 2. J. Biol. Chem. 279, 31157-31163.
14. Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
15. Finkel, T. (2003). Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.
16. Georgiou, G. and Masip, L. (2003). An overoxidation journey with a return ticket. Science 300, 592-594.
17. Griffiths, S. D., Clarke, A. R., Healy, L. E., Ross, G., Ford, A. M., Hooper, M. L., Wyllie, A. H. and Greaves, M. (1997). Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 14, 523-531.
18. Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R. and Glazer, P. M. (1995). p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res. 55, 4420-4424.
19. Hengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J. and Scheffner, M. (2001). Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad Sci. USA 98, 1218-1223.
20. Hietanen, S., Lain, S., Krausz, E., Blattner, C. and Lane, D. P. (2000). Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA 97, 8501-8506.
21. Hoppe-Seyler, F. and Butz, K. (1993). Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67, 3111-3117.
22. Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okumura, S. et al. (2004). p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 64, 2350-2356.
23. Jackson, A. L. and Loeb, L. A. (2001). The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477, 7-21.
24. Jeon, S., Allen-Hoffmann, B. L. and Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69, 2989-2997.
25. Klungland, A., Rosewell, I., Hollenbach, S., Larsen, E., Daly, G., Epe, B., Seeberg, E., Lindahl, T. and Barnes, D. E. (1999). Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad Sci. USA 13300-13305.
26. Lane, D. P. (1992). p53, guardian of the genome. Nature 358, 15-16.
27. Lazo, P. A. (1999). The molecular genetics of cervical carcinoma. Br. J. Cancer 80, 2008-2018.
28. Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S. W. and Aaronson, S. A. (2003). Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23, 8576-8585.
29. Martindale, J. L. and Holbrook, N. J. (2002). Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.
30. Nohl, H., Kozlov, A. V., Gille, L. and Staniek, K. (2003). Cell respiration and formation of reactive oxygen species: facts and artifacts. Biochem. Soc. Trans. 31, 1308-1311.
31. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. and Vogelstein, B. (1997). A model for p53-induced apoptosis. Nature 389, 300-305.
32. Rabilloud, T., Heller, M., Gasnier, F., Luche, S., Rey, C., Aebersold, R., Benahmed, M., Louisot, P. and Lunardi, J. (2002). Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277, 19306-19401.
33. Renschler, M. F. (2004). The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer 40, 1934-1940.
34. Rhee, S. G., Kang, S. W., Chang, T. S., Jeong, W. and Kim, K. (2001). Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52, 35-41.
35. Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Appova, L. S., Kravchenko, J. E. and Chumakov, P. M. (2005). The antioxidant function of the p53 tumor suppressor. Nat. Med. 11, 1306-1313.
36. Scheffner, M. (1998). Ubiquitin, E6-AP, and their role in p53 inactivation. Pharmacol. Ther. 78, 129-139.
37. Scheffner, M., Munger, K., Byrne, J. C. and Howley, P. M. (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88, 5523-5527.
38. Sengupta, S. and Harris, C. C. (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6, 44-55.
39. Storz, G. and Imlay, J. A. (1999). Oxidative stress. Curr. Opin. Microbiol. 2, 188-194.
40. Struthers, L., Patel, R., Clark, J. and Thomas, S. (1998). Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal. Biochem. 255, 20-31.
41. Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W. and Sun, Y. (1999). Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274, 12061-12066.
42. Thannickal, V. J. and Fanburg, B. L. (2000). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1005-L1028.
43. Waris, G. and Ahsan, H. (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 5, 14.
44. Wiseman, H. and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313, 17-29.
45. Woo, H. A., Chae, H. Z., Hwang, S. C., Yang, K. S., Kang, S. W., Kim, K. and Rhee, S. G. (2003). Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300, 653-656.
46. Wood, Z. A., Poole, L. B. and Karplus, P. A. (2003). Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300, 650-653.
47. Yang, K. S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K. and Rhee, S. G. (2002). Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277, 38029-38036.
48. Yoon, K. A., Nakamura, Y. and Arakawa, H. (2004). Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49, 134-140.
49. zur Hausen, H. (1996). Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288, F55-F78.